Shandong Sinoglory Health Food Co., Ltd (SHA:603182)
China · Delayed Price · Currency is CNY 16.20
-0.19 (-1.16%)
At close: Feb 12, 2026
SHA:603182 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,404 | 1,484 | 1,690 | 1,609 | 1,230 | 966.07 |
Other Revenue | 4.19 | 4.19 | 4.09 | 3.91 | 4.28 | 2.48 |
| 1,409 | 1,488 | 1,695 | 1,613 | 1,234 | 968.55 | |
Revenue Growth (YoY) | -8.80% | -12.17% | 5.05% | 30.69% | 27.43% | 11.34% |
Cost of Revenue | 1,217 | 1,309 | 1,486 | 1,405 | 1,075 | 832.52 |
Gross Profit | 191.59 | 179.49 | 208.37 | 208.37 | 159.24 | 136.03 |
Selling, General & Admin | 42.94 | 41.52 | 42.62 | 38.25 | 32.91 | 26.69 |
Research & Development | 9.57 | 10.41 | 9.9 | 16.67 | 17.13 | 8.39 |
Other Operating Expenses | 6.13 | 4.61 | 6.3 | 8.45 | 5.14 | -2.79 |
Operating Expenses | 50.27 | 49.28 | 67.16 | 63.67 | 56.74 | 32.35 |
Operating Income | 141.32 | 130.21 | 141.21 | 144.69 | 102.5 | 103.67 |
Interest Expense | -0.63 | -0.63 | -1.56 | -3.18 | -3.98 | -2.92 |
Interest & Investment Income | 1.01 | 4.36 | 7.13 | 2.77 | 2.84 | 1.61 |
Currency Exchange Gain (Loss) | 5.66 | 5.66 | 1.88 | 6.98 | -2.31 | -4.63 |
Other Non Operating Income (Expenses) | -0.41 | -0.47 | -0.36 | -4.31 | -0.27 | -0.56 |
EBT Excluding Unusual Items | 146.95 | 139.13 | 148.31 | 146.96 | 98.77 | 97.17 |
Gain (Loss) on Sale of Investments | -0.22 | - | - | -9.25 | 0.53 | 0.19 |
Gain (Loss) on Sale of Assets | -0.31 | -0.01 | -0.92 | 0.03 | -0.99 | 0.18 |
Asset Writedown | 0.38 | -0.12 | -0.27 | -0.31 | - | -0.03 |
Other Unusual Items | 3.45 | 3.69 | 1.3 | 10.86 | 3.32 | - |
Pretax Income | 150.24 | 142.69 | 148.41 | 148.3 | 101.63 | 97.51 |
Income Tax Expense | 35.4 | 33.55 | 38.28 | 33.92 | 22.48 | 23.43 |
Net Income | 114.84 | 109.14 | 110.14 | 114.38 | 79.15 | 74.09 |
Net Income to Common | 114.84 | 109.14 | 110.14 | 114.38 | 79.15 | 74.09 |
Net Income Growth | 13.96% | -0.91% | -3.71% | 44.51% | 6.83% | 0.19% |
Shares Outstanding (Basic) | 164 | 165 | 164 | 133 | 124 | 123 |
Shares Outstanding (Diluted) | 164 | 165 | 164 | 133 | 124 | 123 |
Shares Change (YoY) | -0.80% | 0.59% | 23.59% | 7.54% | 0.21% | - |
EPS (Basic) | 0.70 | 0.66 | 0.67 | 0.86 | 0.64 | 0.60 |
EPS (Diluted) | 0.70 | 0.66 | 0.67 | 0.86 | 0.64 | 0.60 |
EPS Growth | 14.88% | -1.49% | -22.09% | 34.38% | 6.67% | 0.13% |
Free Cash Flow | -34.24 | -85.73 | -117.45 | 63.88 | 9.64 | 38.63 |
Free Cash Flow Per Share | -0.21 | -0.52 | -0.71 | 0.48 | 0.08 | 0.31 |
Dividend Per Share | 0.400 | 0.100 | 0.400 | 0.300 | - | - |
Dividend Growth | - | -75.00% | 33.33% | - | - | - |
Gross Margin | 13.60% | 12.06% | 12.30% | 12.92% | 12.90% | 14.04% |
Operating Margin | 10.03% | 8.75% | 8.33% | 8.97% | 8.30% | 10.70% |
Profit Margin | 8.15% | 7.33% | 6.50% | 7.09% | 6.41% | 7.65% |
Free Cash Flow Margin | -2.43% | -5.76% | -6.93% | 3.96% | 0.78% | 3.99% |
EBITDA | 173.45 | 163.32 | 175.63 | 178.26 | 130.27 | 129.85 |
EBITDA Margin | 12.31% | 10.97% | 10.36% | 11.05% | 10.55% | 13.41% |
D&A For EBITDA | 32.13 | 33.11 | 34.42 | 33.57 | 27.78 | 26.18 |
EBIT | 141.32 | 130.21 | 141.21 | 144.69 | 102.5 | 103.67 |
EBIT Margin | 10.03% | 8.75% | 8.33% | 8.97% | 8.30% | 10.70% |
Effective Tax Rate | 23.56% | 23.52% | 25.79% | 22.87% | 22.12% | 24.02% |
Revenue as Reported | 1,409 | 1,488 | 1,695 | 1,613 | 1,234 | - |
Advertising Expenses | - | 0.48 | 0.35 | 0.23 | 0.11 | - |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.